AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Agios Pharmaceuticals, Inc.

$30.55 +$3.37 (+12.40%)
NASDAQ · 30 Oct 2026 20:00 UTC
Previous Close
$37.23
Day Range
$29.80$33.77
Year Range
$22.24$46.00
Market Cap
1.82B
AVG Volume
1.14M
Trailing/Forward PE
-4.36/-
PEG ratio
0.24
Dividend Yield
-
Next Earnings Date
2026-11-05
Primary Exchange
NASDAQUS
Revenue (USD) · TTM
025M50M75M100M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
AGIO Revenue (USD) by quarter, trailing twelve months
PeriodRevenue (USD)
26 Q298.34M
26 Q166.05M
25 Q454.03M
25 Q344.79M
25 Q240.88M
25 Q137.03M
24 Q436.5M
24 Q332.87M
24 Q231.31M
24 Q129.4M
Net Income (USD) · TTM
-500M0500M1B24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
AGIO Net Income (USD) by quarter, trailing twelve months
PeriodNet Income (USD)
26 Q2-411.29M
26 Q1-422.6M
25 Q4-412.78M
25 Q3-401.26M
25 Q2650.08M
25 Q1665.99M
24 Q4673.73M
24 Q3674.31M
24 Q2-364.93M
24 Q1-352.62M
Operating Income (USD) · TTM
-600M-400M-200M024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
AGIO Operating Income (USD) by quarter, trailing twelve months
PeriodOperating Income (USD)
26 Q2-459.02M
26 Q1-475.53M
25 Q4-472.13M
25 Q3-475.59M
25 Q2-461.53M
25 Q1-440.29M
24 Q4-425.74M
24 Q3-406.98M
24 Q2-405.06M
24 Q1-392.95M
EBITDA · TTM
Cash Flows · TTM
EPS · TTM
Expenses · TTM
Cash & Debt · TTM
Debt ratios · TTM
Margins · TTM
Return on Capital · TTM
Shares Outstanding · TTM
Dividends (USD) · TTM
Employee Count
Book Value Per Share · TTM
Total Assets · TTM
PE Ratio
Free Cash Flow Yield
Price to Sales
EV/EBITDA
Price/Operating Cashflow
Price to Book

Earnings: AGIO

Estimate against actual revenue and earnings per share, the beat and miss record of recent reports, and how the price moved around each one. Next report: 5 Nov 2026.

Agios Pharmaceuticals, Inc.
AGIO
Stockpicker

Video analysis: AGIO

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: AGIO

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.